TRCT
BGMD

Tower Research Capital (TRC)’s BG MEDICINE INC COM STK NEW BGMD Stock Holding History

Tower Research Capital (TRC)’s Portfolio BGMD Stock Details BGMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-4,084
Closed -$9K – 5340
2014
Q3 		$9K Buy
+4,084
New +$13.7K ﹤0.01% 2948
2014
Q2 		– Sell
-2,815
Closed -$22K – 5198
2014
Q1 		$22K Buy
+2,815
New +$15.6K ﹤0.01% 1808
2013
Q4 		– Sell
-255
Closed -$1K – 5293
2013
Q3 		$1K Sell
255
-114
-31% -$480 ﹤0.01% 4428
2013
Q2 		$2K Buy
+369
New +$2.46K ﹤0.01% 3592

Other funds holding BGMD

AP
AGTC Partners Cambridge, Massachusetts $13.6M AUM 15.62% 1-Year Est. Return
FV2GP
Flagship Ventures 2007 General Partner Cambridge, Massachusetts $107M AUM
GE
General Electric Evendale, Ohio $308M AUM 40.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
VFS
VSR Financial Services Overland Park, Kansas $607M AUM 0.85% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Tower Research Capital (TRC)'s BGMD Position: Q4 2014 in Review

Tower Research Capital (TRC) sold out of BG MEDICINE INC COM STK NEW (BGMD) in Q4 2014, closing a stake of 4,084 shares — an estimated $9K sold.

Tower Research Capital (TRC) first reported a position in BGMD in Q2 2013 and held it in 4 quarters. The position peaked at $22K in Q1 2014. 25 funds tracked by Wall St. Rank hold BGMD as of Q4 2014.

  • Tower Research Capital (TRC) reported no remaining BG MEDICINE INC COM STK NEW position as of Q4 2014 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 4,084 BG MEDICINE INC COM STK NEW shares in Q4 2014, an estimated $9K.
  • Tower Research Capital (TRC) first reported a position in BG MEDICINE INC COM STK NEW in Q2 2013 and held it in 4 quarters.
  • Tower Research Capital (TRC)'s BG MEDICINE INC COM STK NEW position peaked at $22K in Q1 2014.
  • 25 funds tracked by Wall St. Rank held BG MEDICINE INC COM STK NEW as of Q4 2014.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2014, filed 5 Feb 2015.